Screening for volunteers to participate in HIV Vaccine Trials at the Fred Hutchinson Cancer Research Center / University of Washington Vaccine Trials Unit
Research Study Number:
Principal Investigator:
4952
M. Juliana McElrath, MD, PhD - Member, FHCRC Clinical Research/Professor of Medicine, UW
The overall aim of our studies is to evaluate vaccines for safety and the ability to stimulate immune responses in participants. The ideal vaccine for global use should demonstrate proven safety in HIV negative volunteers, tolerability, and confer protection against HIV. Our studies seek to find an affordable vaccine with the potential for mass production in order to meet global needs.
Time commitment will vary depending on the study.
Volunteers must be:
- in good general health
- HIV negative and at low risk for HIV infection
- between 18 to 50 years of age
Both males and females are eligible to participate.
Other eligibility criteria may apply depending on the study.
Persons with 1 or more of the following:
- an illness or condition that would affect the immune response or would require medication that affects the immune response
- an illness or condition that would prohibit repeated blood draws
- an illness or condition in which signs or symptoms could be confused with reactions to vaccine
Other eligibility criteria may apply depending on the study.
FHCRC/UW HIV Vaccine Trials Unit
Cabrini Medical Tower
901 Boren, Suite 1320
(corner of Boren & Madison)
Seattle, Washington
For directions and more information please visit: www.seattlevaccines.org
National Institutes of Health (NIH)
$25 for participation in screening. If enrolled in a vaccine trial, volunteers will receive additional compensation for each completed visit.
Open
Kim Louis, HIV Vaccine Trials Unit
(206) 667-2300
HIV, Infectious Disease, Vaccine Studies
